Evogene Ltd. (EVGN) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12
	20-F	20-F	20-F	20-F	20-F	20-F	20-F	20-F
Revenues	0.0	0.0	0.0	2.4	2.6	2.2	1.2	1.0
Revenue growth				-5.7%	14.7%	90.2%	21.3%
Cost of goods sold	0.0	0.0	0.0	5.6	8.3	9.7	10.1	9.6
Gross profit	0.0	0.0	0.0	-3.2	-5.7	-7.5	-8.9	-8.6
Gross margin				-132.6%	-221.1%	-333.1%	-757.8%	-882.7%
Selling, general and administrative [+]				3.9	4.4	4.2	3.6	2.2
General and administrative	0.0	0.0	0.0	3.9	4.4	4.2	3.6	2.2
Research and development				16.4	14.4	14.0	11.1	7.3
Other operating expenses				-2.4	-6.6	-10.4	-14.9	-14.9
EBIT [+]	0.0	0.0	0.0	-21.1	-17.9	-15.3	-8.7	-3.1
EBIT growth				17.7%	17.5%	74.9%	179.0%
EBIT margin				-870.0%	-697.0%	-680.5%	-739.7%	-321.6%
Other income (expense), net				1.5	0.7	0.7	-0.2	0.7
Pre-tax income	0.0	0.0	0.0	-19.6	-17.2	-14.5	-8.9	-2.4
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Tax rate					0.0%	0.0%	0.0%
Net income	0.0	0.0	0.0	-19.6	-17.2	-14.5	-8.9	-2.5
Net margin				-808.3%	-669.5%	-648.1%	-753.0%	-259.5%

Basic EPS [+]				($0.77)	($0.68)	($0.58)	($0.45)	($0.14)
Growth				13.2%	17.2%	28.9%	221.4%
Diluted EPS [+]				($0.77)	($0.68)	($0.58)	($0.45)	($0.14)
Growth				13.2%	17.2%	28.9%	221.4%

Shares outstanding (basic) [+]				25.4	25.3	25.1	19.7	18.0
Growth				0.5%	1.0%	27.0%	9.5%
Shares outstanding (diluted) [+]				25.4	25.3	25.1	19.7	18.0
Growth				0.5%	1.0%	27.0%	9.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.